SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin αvß6

Carcinogenesis

Volumn 35, Issue 2, 2014, Pages 282-291

  Wang, Ben ^a,b   Wang, Wenke ^b   Niu, Weibo ^a   Liu, Enyu ^a   Liu, Xiangjuan ^b   Wang, Jiayong ^a   Peng, Cheng ^a   Liu, Song ^a   Xu, Ling ^a   Wang, Lei ^c   Niu, Jun ^a  

^a Department of Hepatobiliary Surgery ^*  (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAVBETA6 INTEGRIN; CHEMOKINE RECEPTOR CXCR4; MITOGEN ACTIVATED PROTEIN KINASE; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CELL MIGRATION; CELL STRAIN CACO 2; CELL STRAIN HT29; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION; UPREGULATION;

ANTIGENS, NEOPLASM; APOPTOSIS; BLOTTING, WESTERN; CACO-2 CELLS; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; COLORECTAL NEOPLASMS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HT29 CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; INTEGRINS; LIVER NEOPLASMS; PROTO-ONCOGENE PROTEIN C-ETS-1; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84893404432     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt331     Document Type: Article

References (50)

1. Steinert,G. et al. (2012) Biology and significance of circulating and disseminated tumour cells in colorectal cancer. Langenbecks. Arch. Surg., 397, 535-542.
2. Molleví,D.G. et al. (2007) Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection. Carcinogenesis, 28, 1241-1246.
3. Nguyen,D.X. et al. (2009) Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer, 9, 274-284.
4. Fidler,I.J. (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer, 3, 453-458.
5. Koizumi,K. et al. (2007) Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci., 98, 1652-1658.
6. Lira,S.A. et al. (2012) The biology of chemokines and their receptors. Immunol. Res., 54, 111-120.
7. Yoshie,O. et al. (1997) Novel lymphocyte-specific CC chemokines and their receptors. J. Leukoc. Biol., 62, 634-644.
8. Zlotnik,A. et al. (2000) Chemokines: a new classification system and their role in immunity. Immunity, 12, 121-127.
9. Kim,J. et al. (2005) Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J. Clin. Oncol., 23, 2744-2753.
10. Ottaiano,A. et al. (2006) Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Clin. Cancer Res., 12, 2795-2803.
11. Yoshitake,N. et al. (2008) Expression of SDF-1 alpha and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer. Br. J. Cancer, 98, 1682-1689.
12. Müller,A. et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature, 410, 50-56.
13. Taichman,R.S. et al. (2002) Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res., 62, 1832-1837.
14. Su,L. et al. (2005) Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells. Clin. Cancer Res., 11, 8273-8280.
15. Kajiyama,H. et al. (2008) Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int. J. Cancer, 122, 91-99.
16. Tan,C.T. et al. (2008) CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway. Carcinogenesis, 29, 1519-1527.
17. Domanska,U.M. et al. (2013) A review on CXCR4/CXCL12 axis in oncology: no place to hide. Eur. J. Cancer, 49, 219-230.
18. Engl,T. et al. (2006) CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. Neoplasia, 8, 290-301.
19. Jones,J. et al. (2007) CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells. Exp. Cell Res., 313, 4051-4065.
20. Hynes,R.O. (2002) Integrins: bidirectional, allosteric signaling machines. Cell, 110, 673-687.
21. Bandyopadhyay,A. et al. (2009) Defining the role of integrin alphavbeta6 in cancer. Curr. Drug Targets, 10, 645-652.
22. Niu,J. et al. (1998) Integrin-mediated signalling of gelatinase B secretion in colon cancer cells. Biochem. Biophys. Res. Commun., 249, 287-291.
23. Yang,G.Y. et al. (2008) Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver. Cancer Sci., 99, 879-887.
24. Zhang,Z.Y. et al. (2008) Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma. Clin. Oncol. (R. Coll. Radiol)., 20, 61-66.
25. Zhao-Yang,Z. et al. (2008) Signaling and regulatory mechanisms of integrin alphavbeta6 on the apoptosis of colon cancer cells. Cancer Lett., 266, 209-215.
26. Peng,C. et al. (2009) Norcantharidin induces HT-29 colon cancer cell apoptosis through the alphavbeta6-extracellular signal-related kinase signaling pathway. Cancer Sci., 100, 2302-2308.
27. Niu,W. et al. (2010) Effects of alphavbeta6 gene silencing by RNA interference in PANC-1 pancreatic carcinoma cells. Anticancer Res., 30, 135-142.
28. Liu,S. et al. (2013) The ß6-integrin-ERK/MAP kinase pathway contributes to chemo resistance in colon cancer. Cancer Lett., 328, 325-334.
29. Wang,J. et al. (2011) PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin alphavbeta6. Cancer Lett., 311, 38-47.
30. Maréchal,R. et al. (2009) High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. Br. J. Cancer, 100, 1444-1451.
31. Tang,C.H. et al. (2008) Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis. Carcinogenesis, 29, 35-43.
32. Zirvi,K.A. et al. (1993) Sensitivity of human colon tumor metastases to anticancer drugs in athymic (nude) mice. Cancer Lett., 72, 39-44.
33. Sato,M. et al. (1997) Interaction between human cancer cells and cultured murine endothelial cells, and its relationship with metastatic potential. Int. J. Oncol., 10, 1173-1178.
34. Hamada,K. et al. (2008) Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice. Int. J. Oncol., 32, 153-159.
35. Tammali,R. et al. (2011) Inhibition of aldose reductase prevents colon cancer metastasis. Carcinogenesis, 32, 1259-1267.
36. Lai,T.H. et al. (2009) Stromal cell-derived factor-1 increase alphavbeta3 integrin expression and invasion in human chondrosarcoma cells. J. Cell. Physiol., 218, 334-342.
37. Sun,Y.X. et al. (2007) Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells. Prostate, 67, 61-73.
38. Niu,J. et al. (2002) Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the beta6 integrin subunit. Int. J. Cancer, 99, 529-537.
39. Huang,W.S. et al. (2012) Stromal cell-derived factor-1/CXC receptor 4 and ß1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells. J. Cell. Physiol., 227, 1114-1122.
40. Bates,R.C. et al. (2005) Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J. Clin. Invest., 115, 339-347.
41. Stamatovic,S.M. et al. (2006) CCL2 regulates angiogenesis via activation of Ets-1 transcription factor. J. Immunol., 177, 2651-2661.
42. Ulrich,F. et al. (2009) Trafficking and cell migration. Traffic, 10, 811-818.
43. Scala,S. et al. (2005) Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin. Cancer Res., 11, 1835-1841.
44. Burger,M. et al. (2003) Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells. Oncogene, 22, 8093-8101.
45. Engl,T. et al. (2006) Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix. Life Sci., 78, 1784-1793.
46. Spano,J.P. et al. (2004) Chemokine receptor CXCR4 and early-stage nonsmall cell lung cancer: pattern of expression and correlation with outcome. Ann. Oncol., 15, 613-617.
47. Huang,Y.C. et al. (2007) Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-kappaBdependent pathway in human lung cancer cells. Biochem. Pharmacol., 74, 1702-1712.
48. Teicher,B.A. et al. (2010) CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin. Cancer Res., 16, 2927-2931.
49. Callaway,K.A. et al. (2006) Properties and regulation of a transiently assembled ERK2.Ets-1 signaling complex. Biochemistry, 45, 13719-13733.
50. Milkiewicz,M. et al. (2008) Shear stress-induced Ets-1 modulates protease inhibitor expression in microvascular endothelial cells. J. Cell. Physiol., 217, 502-510.